These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 4505664

  • 1. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
    Stewart WE, De Clercq E, Billiau A, Desmyter J, De Somer P.
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
    [Abstract] [Full Text] [Related]

  • 2. Production, purification and characterization of rat interferon.
    Lin LS, Abreu SL.
    Arch Virol; 1979 Jul; 62(3):221-7. PubMed ID: 42377
    [Abstract] [Full Text] [Related]

  • 3. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
    Levy HB, Riley FL, Lvovsky E, Stephen EE.
    Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interferon induced by polyinosinic-polycytidylic acid in interferon pretreated L cells in absence of DEAE-dextran.
    Rosztóczy I.
    Acta Virol; 1971 Sep; 15(5):431. PubMed ID: 4399145
    [No Abstract] [Full Text] [Related]

  • 6. Molecular species of interferon induced in mouse L cells by Newcastle disease virus and polyriboinosinic-polyribocytidylic acid.
    Erickson JS, Paucker K.
    J Gen Virol; 1979 Jun; 43(3):521-9. PubMed ID: 479847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
    Emeny JM, Morgan MJ.
    J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Physical and biological properties of deae-dextran--polyriboinosinic: polyribocytidylic acid complexes.
    Mécs I, Rosztóczy I.
    Acta Virol; 1971 Jul; 15(4):280-5. PubMed ID: 4398078
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interferon production in glia and glioma cell lines.
    Larsson I, Landström LE, Larner E, Lundgren E, Miörner H, Strannegård L.
    Infect Immun; 1978 Dec; 22(3):786-9. PubMed ID: 730383
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship of cytotoxicity and interferon-inducing activity of polyriboinosinic acid. Polyribocytidylic acid to the molecular weights of the homopolymers.
    Stewart WE, De Clercq E.
    J Gen Virol; 1974 Apr; 23(1):83-9. PubMed ID: 4833602
    [No Abstract] [Full Text] [Related]

  • 16. Refractory state of cells to interferon induction.
    Rousset S.
    J Gen Virol; 1974 Jan; 22(1):9-20. PubMed ID: 4360396
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of interferon and host resistance in vivo by double-stranded complexes of copolyribonucleotide of isosinic and guanylic with polyribocytidylic acid.
    Matsuda S, Kida M, Shirafuji H, Yoneda M, Yaoi H.
    Arch Gesamte Virusforsch; 1971 Jan; 34(2):105-18. PubMed ID: 4345742
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.